1-5 of 5
Brian Jonas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Decreased Early Mortality Associated with Treatment of Acute Myeloid Leukemia (AML) at NCI-Designated Cancer Centers in California

Free
Gwendolyn Ho, MD, Ted Wun, MD, Qian Li, MS, Ann M Brunson, MS, Aaron S Rosenberg, MD MS, Brian Jonas, MD PhD, Theresa Keegan, PhD MS
Journal: Blood
Blood (2016) 128 (22): 391.
https://doi.org/10.1182/blood.V128.22.391.391
Published: 2016
Journal Articles

Secondary Acute Lymphoblastic Leukemia (sALL) Is Associated with a Distinct Group of Primary Cancers and Has Prognostic Impact

Free
Aaron S Rosenberg, MD MS, Ann M Brunson, BS, Theresa HM Keegan, PhD MSc, Joseph Tuscano, MD, Ted Wun, MD, Brian Jonas, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1305.
https://doi.org/10.1182/blood.V126.23.1305.1305
Published: 2015
Journal Articles

The Effect of Autologous Stem Cell Transplant (ASCT) on Survival in Californians with Multiple Myeloma (MM) in the Era of Modern Treatment

Free
Aaron S Rosenberg, MD MS, Ann M Brunson, BS, Theresa HM Keegan, PhD MSc, Brian Jonas, MDPhD, Joseph Tuscano, MD, Ted Wun, MD
Journal: Blood
Blood (2015) 126 (23): 1991.
https://doi.org/10.1182/blood.V126.23.1991.1991
Published: 2015
Journal Articles

A Phase 1b Study of Venetoclax (ABT-199/GDC-0199) in Combination with Decitabine or Azacitidine in Treatment-Naive Patients with Acute Myelogenous Leukemia Who Are ≥ to 65 Years and Not Eligible for Standard Induction Therapy

Free
Courtney DiNardo, MD, Daniel Pollyea, MD MS, Keith Pratz, MD, Michael J. Thirman, MD, Anthony Letai, MD PhD, Mark Frattini, MD PhD, Brian Jonas, MDPhD, Joel Leverson, PhD, Ming Zhu, PhD, Martin Dunbar, DrPH, Nancy Falotico, Rachel Kirby, BA, Suresh Agarwal, PhD, Mack Mabry, MD, Jalaja Potluri, MD, Rod A. Humerickhouse, MD PhD, Hagop M. Kantarjian, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 327.
https://doi.org/10.1182/blood.V126.23.327.327
Published: 2015
Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Free
Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD
Journal: Blood
Blood (2013) 122 (21): 3838.
https://doi.org/10.1182/blood.V122.21.3838.3838
Published: 2013